within Pharmacolibrary.Drugs.ATC.N;

model N02CA01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.32,
    Cl             = 41 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,
    adminCount     = 1,
    Vd             = 0.566,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0009166666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Dihydroergotamine is an ergot alkaloid medication primarily used for the treatment of migraine headaches and cluster headaches. It acts as a vasoconstrictor of intracranial arteries, and as an agonist at serotonin (5-HT1) receptors. It is approved and still in use for acute migraine attacks by several regulatory agencies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for nasal spray administration in healthy adults.</p><h4>References</h4><ol><li><p>Humbert, H, et al., &amp; Lavène, D (1996). Human pharmacokinetics of dihydroergotamine administered by nasal spray. <i>Clinical pharmacology and therapeutics</i> 60(3) 265–275. DOI:<a href=&quot;https://doi.org/10.1016/S0009-9236(96)90053-3&quot;>10.1016/S0009-9236(96)90053-3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8841149/&quot;>https://pubmed.ncbi.nlm.nih.gov/8841149</a></p></li><li><p>Silvestro, M, et al., &amp; Russo, A (2024). Dihydroergotamine mesylate nasal spray: an acute treatment option for migraine in adults. <i>Expert review of neurotherapeutics</i> 24(6) 555–564. DOI:<a href=&quot;https://doi.org/10.1080/14737175.2024.2342446&quot;>10.1080/14737175.2024.2342446</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38655598/&quot;>https://pubmed.ncbi.nlm.nih.gov/38655598</a></p></li><li><p>Shrewsbury, SB (2023). The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space. <i>Pharmaceutical medicine</i> 37(6) 451–461. DOI:<a href=&quot;https://doi.org/10.1007/s40290-023-00495-7&quot;>10.1007/s40290-023-00495-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/37537422/&quot;>https://pubmed.ncbi.nlm.nih.gov/37537422</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02CA01_1;
